| |
| |
|
| Insider
Information: |
Biller Scott |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
33,729 |
|
|
Indirect Shares
|
53,059 |
|
|
| Direct
Value |
$1,158,254 |
|
|
|
Indirect Value
|
$1,822,046 |
|
|
| Total
Shares |
86,788 |
|
|
| Total
Value |
$2,980,300 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Agios Pharmaceuticals Inc |
AGIO |
Chief Scientific Officer |
2019-06-11 |
33,729 |
2019-06-11 |
53,059 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
121 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-01-21 |
4 |
OE |
$0.47 |
$2,805 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-01-21 |
4 |
AS |
$34.71 |
$208,265 |
D/D |
(6,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-02-03 |
4 |
AS |
$25.97 |
$155,796 |
D/D |
(6,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-02-03 |
4 |
OE |
$0.47 |
$2,805 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-03-03 |
4 |
AS |
$29.85 |
$179,124 |
D/D |
(6,000) |
0 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-03-03 |
4 |
OE |
$0.47 |
$2,805 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-04-01 |
4 |
AS |
$38.08 |
$171,360 |
D/D |
(4,500) |
30,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-04-01 |
4 |
OE |
$0.47 |
$16,129 |
D/D |
34,500 |
34,500 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-05-01 |
4 |
AS |
$42.39 |
$190,755 |
D/D |
(4,500) |
30,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-05-01 |
4 |
OE |
$0.47 |
$2,104 |
D/D |
4,500 |
34,500 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-06-02 |
4 |
OE |
$0.47 |
$2,104 |
D/D |
4,500 |
34,500 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-06-02 |
4 |
AS |
$33.76 |
$151,920 |
D/D |
(4,500) |
30,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-06-20 |
4 |
AS |
$50.05 |
$100,300 |
D/D |
(2,004) |
30,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-06-20 |
4 |
OE |
$0.47 |
$937 |
D/D |
2,004 |
32,004 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-07-01 |
4 |
AS |
$46.52 |
$209,340 |
D/D |
(4,500) |
30,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-07-01 |
4 |
OE |
$0.47 |
$2,104 |
D/D |
4,500 |
34,500 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-08-01 |
4 |
OE |
$0.47 |
$2,104 |
D/D |
4,500 |
34,500 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-08-01 |
4 |
AS |
$39.09 |
$175,905 |
D/D |
(4,500) |
30,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-08-07 |
4 |
OE |
$0.47 |
$2,338 |
D/D |
5,000 |
35,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-09-02 |
4 |
AS |
$46.30 |
$208,350 |
D/D |
(4,500) |
35,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-09-02 |
4 |
OE |
$0.47 |
$2,104 |
D/D |
4,500 |
39,500 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-09-19 |
4 |
OE |
$0.47 |
$17,763 |
D/D |
37,996 |
72,996 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-09-19 |
4 |
AS |
$50.45 |
$1,916,898 |
D/D |
(37,996) |
35,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-10-01 |
4 |
AS |
$60.07 |
$270,315 |
D/D |
(4,500) |
35,000 |
0 |
- |
|
| AGIO |
Agios Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2014-10-01 |
4 |
OE |
$0.47 |
$2,104 |
D/D |
4,500 |
39,500 |
0 |
- |
|
121 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
